Acro Biomedical Co., Ltd. Share Price Other OTC
Equities
ACBM
US0048921052
Food Processing
Sales 2021 | 1.2M 99.93M | Sales 2022 | 658K 54.95M | Capitalization | 270M 22.55B |
---|---|---|---|---|---|
Net income 2021 | -7M -584M | Net income 2022 | -15M -1.25B | EV / Sales 2021 | 233 x |
Net cash position 2021 | 24.08K 2.01M | Net Debt 2022 | 98.69K 8.24M | EV / Sales 2022 | 410 x |
P/E ratio 2021 |
-32.5
x | P/E ratio 2022 |
-17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 50.03% |
Managers | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30/17/30 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30/17/30 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
1st Jan change | Capi. | |
---|---|---|
+13.21% | 8.01B | |
+1.64% | 7.36B | |
+12.30% | 6.54B | |
-6.99% | 3.73B | |
-7.95% | 3.42B | |
-4.78% | 1.24B | |
+12.61% | 935M | |
-43.32% | 886M | |
-22.54% | 827M |